WELCOME TO THE BRITISH ASSOCIATION FOR THE STUDY OF THE LIVER

This survey is intended for clinicians and allied health care professionals to help inform current provision of MDT practice in the UK and ultimately to inform best practice. The purpose of the project is intended predominantly to apply to HB cancer MDTs, although other forms of MDT and cancer MDTs may be touched on. It intends to map current practice and attitudes to HB cancer MDTs. More importantly it aims to identify inequalities in access to care and expertise and to provide universal standards that can be applied across the NHS and perhaps wider healthcare systems.

The survey will be derived from UK MDT centres whilst a separate Delphi process will be generated through a multi-disciplinary body of experts (medical, nursing, AHPs) across the specialties, and also patients and patient groups and charities. As an endpoint, the working group wants their findings to be published in a peer-reviewed journal and to be disseminated to National bodies, e.g. NHS bodies in England, Northern Ireland, Scotland and Wales, along with Cancer alliances and NHS trusts.

Please complete the survey and forward it to other members of your MDT, including surgeons, medical and clinical oncologists, clinical nurse specialists, radiologists (diagnostic and interventional), histopathologists, gastroenterologists, hepatologists and other allied health professionals who are involved in HB care. 

The survey may take 10-15 minutes to complete but it is important we get as many responses as possible so completion would be appreciated.

Survey link: https://www.surveymonkey.com/r/KYHBDSV 

The closing date for completion of the survey is 3rd June 2026.

Contact admin@basl.org.uk for any questions.

Thank you for taking part.

Kind regards,
Tim Cross
Past President BASL

The National Clinical Impact Awards 2026 round opened on 1st April 2026.

The application window will remain open for seven weeks, closing at 17:00 on 20th May 2026.

Guidance for the 2026 National Clinical Impact Awards has been published here> Applying for a national Clinical Impact Award in 2026 - GOV.UK

A short guide for applicants can be found HERE.

Funding is for 2 Clinical Research Fellows in Hepatology to contribute to the further development of an extensive research program. These posts will commence in September on a fixed term contract for 12 months in the first instance, renewable for a maximum of 3 years depending on progress towards an MD or PhD.

There has been significant investment and growth in liver research at the Peninsula Medical School, with excellent laboratory facilities present adjacent to Derriford Hospital at the Derriford Research Facility where the Hepatology Research Group ( https://www.plymouth.ac.uk/research/hepatology-research-group ) and the Centre of Environmental Hepatology (https://www.plymouth.ac.uk/research/centre-of-environmental-hepatology ) are based. Active clinical research programs span alcohol related liver disease, the use of big data and AI for early liver disease detection, to mechanisms of protection from viral hepatitis. The Centre of Environmental Hepatology, led by Professor Shilpa Chokshi, has a cutting edge and expanding program of translational and basic science work looking at the impact of micro- and nanolastics on liver health. The research programs are delivered and supported by a strong team of senior post-doctoral scientists, clinical research fellows, and PhD students.

Read and apply via the NHS Jobs website under reference 216-G3-HEP7796852

Closing date extended to 20th April 2026

Informal enquiries welcomed with interviews scheduled for April - please contact Professor Matthew Cramp or Professor Ashwin Dhanda, matthew.cramp@nhs.net or ashwin.dhanda@plymouth.ac.uk.